Presentation AHA 2023 Hypertension Treatment in Nigeria: Early Results of a Type 2 Hybrid Effectiveness and Implementation Interrupted Time Series Trial Presenter: Dike Ojji November 17, 2023 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Hypertension Presentation AHA 2023 Up Next Presentation AHA 2023 Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial Presenter: Jamie Kitt November 17, 2023 More slides + Presentation AHA 2023 Population Health and Obesity: Achieving Equity and Feasibility Presenter: Tiffany M. Powell-Wiley November 11, 2023 Presentation AHA 2023 Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen November 11, 2023 We Recommend
Presentation AHA 2023 Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial Presenter: Jamie Kitt November 17, 2023
Presentation AHA 2023 Population Health and Obesity: Achieving Equity and Feasibility Presenter: Tiffany M. Powell-Wiley November 11, 2023
Presentation AHA 2023 Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen November 11, 2023